Iodine -131 Products

131I based products are one of the oldest radiopharmaceuticals for diagnostic and therapeutic applications in thyroid related disorders.

Iodine_131 capsules

BRIT has launched I-131 lipiodol injection for treatment of Hepatocellular carcinoma Code (IOM-40)

BRIT has recently introduced high dose sodium [131I]-iodide capsules in the range of 25 mCi to 100 mCi (IOM 5B). Frequency of supply for I-131 labelled MIBG (IOM 50) has also been enhanced considerably.

CodeProduct Description Diagnostic/Therapeutic useDespacth
IOM 1 sodium [131 I]-Iodide solution Studies of thyroid uptake, Radio iodine therapy and thyroid cancer metastases. Weekly (Friday)
IOM 1B sodium [131 I]-Iodide solution (bulk >500 mCi) Therapeutic treatment of thyrotoxicosis and carcinoma of the thyroid Weekly (Friday)
IOM 2 sodium [131 I]-Iodide - diagnostic capsules
Studies of thyroid uptake and thyroid metastases Weekly (Friday)
IOM 5 sodium  [131 I]-iodide - therapy capsules
Radioiodine therapy for thyrotoxicosis Weekly (Friday)
IOM 5B sodium  [131 I]-iodide - high dose therapy capsules
Radioiodine therapy for thyrotoxicosis Weekly (Friday)
IOM 40 [131 I]-lipiodol Injection Treatment of hepatocellular carcinoma Monthly
IOM 50 [131 I]-meta-iodobenzylguanidine (mIBG) diagnostic dose
Scintigraphy in the investigation of pheochromocytoma, neuroblastoma and assessment of adrenal medullary hyperplasia Weekly (Saturday)
IOM 50T [131 I]-meta-iodobenzylguanidine (mIBG) therapeutic dose
Therapeutic use Fortnightly (Saturday)
Updated: Friday August 02, 2019 21:22